Caidya Executive and Leadership Team

Barbara Kunz, the Chief Executive Officer at Caidya, directs the overarching strategy and operational framework for the multi-therapeutic clinical research organization. Kunz guides Caidya's mission to deliver excellence and an elevated customer experience to innovators worldwide, ensuring seamless support across the entire clinical development lifecycle, from pre-IND strategy through submission and post-marketing surveillance. This leadership role involves fostering strong partnerships and driving the company's growth trajectory by championing its vast therapeutic expertise and commitment to data-driven decision-making. Barbara Kunz ensures the organization consistently meets the evolving needs of its global clientele, maintaining Caidya's position as a premier CRO. The Chief Executive Officer's focus remains on strategic expansion and maintaining the highest standards of trial transparency and efficiency.

Holly Guile, the Chief of Staff & Chief Executive Officer, Office at Caidya, manages critical operational functions and strategic initiatives that support the company's global service delivery. Guile ensures seamless coordination across departments, facilitating the execution of Caidya's mission to provide a wide range of clinical services and vast therapeutic expertise to innovators worldwide. This role involves optimizing internal processes and enhancing communication channels to uphold delivery excellence and an elevated customer experience. Holly Guile's oversight extends to supporting the executive team in strategic planning and ensuring alignment with the company's commitment to data-driven decision-making and trial transparency. The Chief of Staff's focus is on operational synergy, enabling Caidya to effectively support partners throughout their clinical development journey.

John Scott, the Senior VP, Information Technology & Chief Information Officer, Clinical Research Organization & Chief Revenue Officer at Caidya, architects the technological infrastructure and revenue generation strategies for the global clinical research organization. Scott oversees the implementation and advancement of industry-leading and proprietary clinical technology, ensuring trial transparency and enabling data-driven decision-making across all partner engagements. This dual role demands a comprehensive understanding of both IT systems and market dynamics, driving operational efficiency while simultaneously expanding Caidya's market reach and revenue streams. John Scott's leadership ensures that technological innovation directly supports the company's mission of delivery excellence and an elevated customer experience. The Chief Information Officer's strategic vision for technology directly impacts the company's ability to support partners from pre-IND strategy through post-marketing surveillance.

David Rifkind, the Chief Legal Officer at Caidya, provides essential legal counsel and strategic guidance for the multi-therapeutic clinical research organization. Rifkind ensures compliance with all regulatory requirements and manages the legal aspects of Caidya's global operations, safeguarding the company's interests and supporting its partners' endeavors. This critical role involves navigating complex legal landscapes to facilitate the company's mission of supporting innovators worldwide from pre-IND strategy through submission and post-marketing surveillance. David Rifkind's expertise is vital in maintaining the integrity of clinical trials and upholding Caidya's commitment to delivery excellence and an elevated customer experience. The Chief Legal Officer's diligence ensures robust legal frameworks are in place to support technological advancements and data-driven decision-making.